Is postoperative adjuvant radioactive iodine ablation therapy always necessary for intermediate-risk papillary thyroid cancer patients with central neck metastasis?
K Han, HM Noh, HM Jeong, YC Lim - Annals of Surgical Oncology, 2021 - Springer
… Papillary thyroid cancer (PTC) is commonly associated with neck lymph node … radioactive
iodine (RAI) ablation therapy. This study aimed to analyze the effectiveness of RAI ablation …
iodine (RAI) ablation therapy. This study aimed to analyze the effectiveness of RAI ablation …
Update on the systemic management of radioactive iodine refractory differentiated thyroid cancer
G Babu, CT Kainickal - Molecular and Clinical …, 2021 - spandidos-publications.com
… followed by remnant thyroid bed ablation using radio‑iodine, as … of patients who are
non‑responsive to radioactive iodine (RAI… efficacy in numerous types of tumor. Targeted therapies …
non‑responsive to radioactive iodine (RAI… efficacy in numerous types of tumor. Targeted therapies …
No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH
MC Campopiano, D Podestà, F Bianchi… - European Journal of …, 2020 - academic.oup.com
… efficacy and the outcome of our two groups of patients. … by radioiodine (131-I) initial treatment,
either for ablation or as … thyroidectomy, 131-I remnant ablation and high activities of 131-I …
either for ablation or as … thyroidectomy, 131-I remnant ablation and high activities of 131-I …
[HTML][HTML] Clinical outcomes of N1b papillary thyroid cancer patients treated with two different doses of radioiodine ablation therapy
M Jin, J Ahn, YM Lee, TY Sung… - Endocrinology and …, 2020 - synapse.koreamed.org
… effectiveness and adverse effects, we need more accurate evidence for the efficacy of higher
doses of RAI as … mCi of RAI for N1b PTC patients is sufficient for remnant ablation. However, …
doses of RAI as … mCi of RAI for N1b PTC patients is sufficient for remnant ablation. However, …
Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade
FA Verburg, G Flux, L Giovanella… - European journal of …, 2020 - Springer
… Search terms used included “differentiated thyroid cancer” and “radioiodine therapy” …
evidence supporting the effectiveness of RIT in these patients. Yang et al. [8] studied 11,832 DTC …
evidence supporting the effectiveness of RIT in these patients. Yang et al. [8] studied 11,832 DTC …
Randomised comparison of 1.1 GBq and 3.7 GBq radioiodine to ablate the thyroid in the treatment of low-risk thyroid cancer: a 13-year follow-up
V Ahtiainen, L Vaalavirta, M Tenhunen… - Acta …, 2020 - Taylor & Francis
… lower activities representing equal effectiveness in ablation of the thyroid remnant into light.
Previous … To eradicate and control papillary or follicular thyroid cancer remnant, radioiodine …
Previous … To eradicate and control papillary or follicular thyroid cancer remnant, radioiodine …
[PDF][PDF] Clinical outcomes of low-dose and high-dose postoperative radioiodine therapy in intermediate-risk papillary thyroid carcinoma patients with low postoperative …
P Chen, JX Luo, W Ouyang, HJ Feng, JQ Wu, J Wang… - 2021 - pdfs.semanticscholar.org
… and commentary examining the effectiveness of radioactive iodine remnant ablation in well…
Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review …
Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review …
[PDF][PDF] Efficacy of 131I therapy and its influencing factors in children and adolescents with differentiated thyroid carcinoma
M Luo, Y Hu - J BUON, 2021 - jbuon.com
… ablation of thyroid remnants was efficacious in 61 (64.9%) patients, but not in 33 (35.1%)
patients … RAIU represents the ability of thyroid tissues and metastases to specifically take in RAI, …
patients … RAIU represents the ability of thyroid tissues and metastases to specifically take in RAI, …
[HTML][HTML] Differentiated thyroid carcinoma: an update
P van Houten, RT Netea-Maier, JW Smit - Best Practice & Research …, 2023 - Elsevier
… stronger evidence for matters such as the indications and application of RAI-remnant ablation
in patients with low-risk DTC, and efficacy of TKIs in advanced DTC. In addition, there is …
in patients with low-risk DTC, and efficacy of TKIs in advanced DTC. In addition, there is …
Recurrent differentiated thyroid cancer: the current treatment options
A Coca-Pelaz, JP Rodrigo, JP Shah, IJ Nixon, DM Hartl… - Cancers, 2023 - mdpi.com
… , RAI is a treatment option that should be considered. Postoperative RAI remnant ablation for
DTC is also intended to ablate … not superior in efficacy to dabrafenib alone for such patients. …
DTC is also intended to ablate … not superior in efficacy to dabrafenib alone for such patients. …